Medicare Enrolled
Dr. Magdolna Solti, MD
Hematology & Oncology · Vancouver, WA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Solti from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Solti?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Solti
Dr. Magdolna Solti is a hematology & oncology specialist in Vancouver, WA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Solti performed 37,012 Medicare services across 2,868 unique beneficiaries.
Between the years covered by Open Payments, Dr. Solti received a total of $522 from 6 pharmaceutical and/or device companies across 6 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Solti is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 9% volume in WA
$522 industry payments
Medicare Practice Summary
Medicare Utilization ↗37,012
Medicare services
Top 9% in WA for hematology & oncology
2,868
Unique beneficiaries
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,851 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
8,140 | $2 | $21 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
7,350 | $0 | $6 |
| Pembrolizumab injection (Keytruda) | 6,801 | $43 | $146 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
3,620 | $0 | $3 |
| Denosumab injection (Prolia/Xgeva) | 1,380 | $19 | $71 |
| Rituximab-pvvr biosimilar injection, 10 mg An injection of rituximab-pvvr, a biosimilar medication, administered in a 10 mg dose. |
1,030 | $22 | $194 |
| Nephelometry test A laboratory test that uses light scattering to measure the concentration of specific substances in a sample. |
914 | $13 | $176 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
760 | $0 | $1 |
| Injection, granisetron hydrochloride, 100 mcg | 700 | $0 | $25 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
644 | $8 | $34 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
597 | $10 | $60 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
564 | $8 | $18 |
| Anti-nausea injection (Aloxi/palonosetron) | 530 | $1 | $122 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
282 | $92 | $331 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
264 | $12 | $102 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
236 | $9 | $52 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
192 | $101 | $666 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
173 | $2 | $300 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
162 | $6 | $462 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
161 | $29 | $243 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
149 | $19 | $93 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 148 | $20 | $120 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
144 | $75 | $1,444 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
141 | $73 | $70 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
133 | $6 | $29 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
122 | $15 | $72 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
107 | $134 | $465 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
99 | $23 | $148 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
96 | $11 | $90 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
91 | $13 | $56 |
| Beta-2 microglobulin level test A blood test that measures the level of beta-2 microglobulin, a protein produced by cells in the body. |
88 | $16 | $93 |
| Iron level test | 86 | $6 | $25 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
86 | $8 | $33 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
80 | $25 | $137 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 79 | $131 | $3,938 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
64 | $23 | $151 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
59 | $14 | $69 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
59 | $48 | $295 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
57 | $1 | $7 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
52 | $6 | $27 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
37 | $1,183 | $3,524 |
| Hepatitis B core antibody test A blood test that measures the level of antibodies to the hepatitis B core antigen. This test helps determine if a person has been infected with the hepatitis B virus. |
37 | $12 | $72 |
| Hepatitis B surface antigen test A blood test that uses an immunoassay technique to detect the presence of the hepatitis B surface antigen. This test identifies whether the hepatitis B virus is currently present in the body. |
37 | $10 | $53 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
37 | $57 | $235 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
36 | $52 | $324 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 36 | $281 | $550 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
34 | $49 | $774 |
| Hepatitis B surface antibody test A blood test that measures the level of antibodies against the hepatitis B surface antigen. This test is used to check for immunity to hepatitis B or to verify the effectiveness of the hepatitis B vaccine. |
32 | $11 | $57 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
31 | $1 | $9 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
29 | $16 | $76 |
| CA 19-9 tumor antigen test A blood test that measures the level of CA 19-9, a substance that can be found in the blood of some people with cancer. This quantitative analysis detects and measures the specific tumor antigen. |
29 | $20 | $120 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
28 | $178 | $1,006 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
19 | $116 | $509 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
19 | $2 | $19 |
| Urine total protein level A laboratory test that measures the total amount of protein present in a urine sample. |
18 | $4 | $20 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
18 | $1 | $19 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
16 | $26 | $242 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
14 | $5 | $29 |
| New patient office visit, complex (60-74 min) | 14 | $174 | $629 |
| Urinalysis, microscopic examination A laboratory test that examines a urine sample under a microscope to check for cells, crystals, bacteria, or other substances. |
13 | $3 | $13 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
13 | $30 | $233 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
13 | $76 | $318 |
| Hepatitis C antibody test A blood test that checks for antibodies to the hepatitis C virus. This test helps determine if a person has been exposed to the virus. |
12 | $14 | $83 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.1% high complexity
85.1% medium
13.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$522
Total received (2021-2024)
Avg $174/year across 3 years
Bottom 41% in WA for hematology & oncology
6
Companies
6
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$326 (62.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$196 (37.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$203
2023
$307
2021
$12
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Stemline Therapeutics Inc.
$118
SANOFI-AVENTIS U.S. LLC
$85
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2021-2024) ›
Incyte Corporation
$125
Stemline Therapeutics Inc.
$118
Janssen Biotech, Inc.
$99
SANOFI-AVENTIS U.S. LLC
$85
Lilly USA, LLC
$83
Gilead Sciences, Inc.
$12
Top 3 companies account for 65.5% of all-time payments
Associated products mentioned in payments ›
IMBRUVICA · JAKAFI · Orserdu · SARCLISA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (62%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
99
Per 100K population
19.4
County median income
$94,948
Nearest hospital
PEACEHEALTH SOUTHWEST MEDICAL CENTER
3.1 mi
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Solti is a mixed practice specialist, with above-average Medicare volume (top 9% in WA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Solti experienced with darbepoetin injection (aranesp) for anemia?
Based on Medicare claims data, Dr. Solti performed 8,140 darbepoetin injection (aranesp) for anemia services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Solti receive payments from pharmaceutical companies?
Yes. Dr. Solti received a total of $522 from 6 companies across 6 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Solti's costs compare to other hematology & oncology specialists in Vancouver?
Dr. Solti's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Solti) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Vancouver
Browse hematology & oncology specialists in Vancouver ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in WA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in WA
Which WA hematology & oncology specialists receive the most from drug and device companies.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
By company
Stemline Therapeutics Inc. Payments to Doctors
See all physicians who received payments from Stemline Therapeutics Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology